Grufity logo
Grufity logo
EVFM

EVFM - Evofem Biosciences Inc Stock Price, Fair Value and News

$0.010.00 (0.00%)
Market Closed as of 30 Jul 2026, 04:00 pm ET

76/100

EVFM

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

76/100

EVFM

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EVFM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EVFM Price Action

EVFM RSI Chart

EVFM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EVFM Valuation

Market Cap

1.3M

Price/Earnings (Trailing)

-0.17

Price/Sales (Trailing)

0.12

EV/EBITDA

0.03

Price/Free Cashflow

4.84

EVFM Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EVFM Fundamentals

EVFM Revenue

Revenue (TTM)

11.5M

Rev. Growth (Yr)

6.39%

Rev. Growth (Qtr)

-81.85%

EVFM Earnings

Earnings (TTM)

-7.9M

Earnings Growth (Yr)

-671.65%

Earnings Growth (Qtr)

-248.31%

EVFM Profitability

EBT Margin

-68.22%

Return on Equity

10.13%

Return on Assets

-105.64%

Free Cashflow Yield

20.67%

EVFM Investor Care

Shares Dilution (1Y)

12.16%

Diluted EPS (TTM)

-0.07

Revenue & Growth

How Evofem Biosciences Inc generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
202611.5M---
202516.6M17.3M17.7M-
202416.0M17.7M17.1M19.4M
202318.4M14.8M13.6M18.2M
202211.4M15.6M20.2M16.8M
20212.4M4.3M6.3M8.2M
2020---446.0K
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Evofem Biosciences Inc

EVFM
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
 CEO
 WEBSITEevofem.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES35

Evofem Biosciences Inc Frequently Asked Questions

EVFM is the stock ticker symbol of Evofem Biosciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Jul 30 2026, market cap of Evofem Biosciences Inc is 1.33 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu Jul 30 2026, EVFM's PE ratio (Price to Earnings) is -0.17 and Price to Sales (PS) ratio is 0.12. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EVFM PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Evofem Biosciences Inc has provided -0.753 (multiply by 100 for percentage) rate of return.